| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |